These studies indicate the involvement of CSF1R expression in cognitive decline during neurodegeneration, while targeting CSF1R signaling may be a viable neuroprotective strategy for PD and other neurodegenerative diseases. The gene discussed is CSF1R; the disease is neurodegenerative disease.